Jake Bauer

Insider Reports History

Location
C/O Myokardia, Inc., 333 Allerton Avenue, South San Francisco, CA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jake Bauer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director Common Stock 25K $367K $14.68 May 1, 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Director Stock Option (Right to Buy) 138K Aug 26, 2025 Direct
Immunovant, Inc. Director Stock Option (Right to Buy) 35.2K May 1, 2025 Direct
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 20.5K Feb 6, 2025 Direct

Insider Reports Filed by Jake Bauer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 26, 2025 1 $0 4 Aug 28, 2025 Director
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 0 $0 3 Aug 18, 2025 Director
IMVT Immunovant, Inc. May 1, 2025 2 $0 4 May 5, 2025 Director
IMVT Immunovant, Inc. Apr 18, 2025 0 $0 3 Apr 28, 2025 Director
ELVN Enliven Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
ARYE ARYA Sciences Acquisition Corp V Jul 12, 2021 0 $0 3 Jul 12, 2021 Director